This inventor holds 28 USPTO granted patents and 4 EPO patents, primarily in Kinase Inhibitors. Top assignees: Chiesi Farmaceutici S.p.a., Genentech, Inc., Corcept Therapeutics Incorporated. Active years: 2009-2021.
Location History:
- Welwyn Garden City, GB (2013)
- Hertfordshire, GB (2009 - 2016)
- Harlow, GB (2010 - 2018)
- Saffron Walden, GB (2019)
- Essex, GB (2018 - 2021)
Company Filing History:
14 out of 341 
9 out of 3,298 
4 out of 138 
Years Active: 2009-2021
Areas of Expertise:
Title: The Innovations of Christopher Hurley: A Pioneer in Pharmaceutical Patents
Introduction:
Christopher Hurley, a talented inventor hailing from Harlow, GB, has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 28 patents. His groundbreaking work focuses on developing Pyridazine derivatives as RORc modulators, offering promising advancements in the treatment of inflammatory diseases like arthritis.
Latest Patents:
Hurley's latest patents showcase his expertise and dedication to advancing medical science. Through the development of Pyridazine derivatives as RORc modulators, he has introduced compounds that have the potential to revolutionize the treatment of inflammatory conditions. These compounds, along with their pharmaceutical salts, demonstrate his commitment to innovation in the pharmaceutical industry.
Career Highlights:
Throughout his career, Hurley has worked with renowned companies such as Chiesi Farmaceutici S.p.a. and Genentech, Inc., where he has continued to push the boundaries of pharmaceutical research and development. His collaborative efforts within these organizations have led to the creation of groundbreaking medications that aim to improve the lives of patients suffering from various diseases.
Collaborations:
Hurley has had the privilege of collaborating with esteemed individuals in the field of pharmaceuticals, including Andrew Peter Cridland and Nicholas Charles Ray. Together, they have combined their expertise to enhance the effectiveness of medical treatments and develop innovative solutions for complex health conditions.
Conclusion:
Christopher Hurley's innovative spirit and unwavering dedication to pharmaceutical research have cemented his status as a pioneer in the field. His invaluable contributions through patents like Pyridazine derivatives as RORc modulators underscore his commitment to advancing medical science and improving patient outcomes. Hurley's work serves as a testament to the profound impact that inventors can have on shaping the future of healthcare.